Advanced search
Publication Cover
HIV Therapy Volume 4, 2010 - Issue 6
Journal homepage
100
Views
1
CrossRef citations to date
0
Altmetric
Review

Regulatory T Cells in HIV Immunotherapy

Bernard JC Macatangay1 HIV/AIDS Program, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAView further author information
&
Charles R Rinaldo2 Department of Infectious Diseases & Microbiology, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. [email protected]Correspondence[email protected]
View further author information
Pages 639-647 | Published online: 14 Dec 2010

Bibliography

  • Sakaguchi S , SakaguchiN, AsanoM, ItohM, TodaM: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J. Immunol.155(3), 1151–1164(1995).
  • Kuniyasu Y , TakahashiT, ItohM, ShimizuJ, TodaG, SakaguchiS: Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T-cell subpopulation.Int. Immunol.12(8), 1145–1155(2000).
  • Taams L , AkbarAN, WaubenMHM (Eds): Regulatory T Cells In Inflammation. Birkhäuser, Basel, Switzerland (2005).
  • von Herrath MG , HarrisonLC: Antigen-induced regulatory T cells in autoimmunity.Nat. Rev. Immunol.3(3), 223–232(2003).
  • Belkaid Y , TarbellK: Regulatory T cells in the control of host–microorganism interactions (*).Annu. Rev. Immunol.27, 551–589(2009).
  • Sakaguchi S , MiyaraM, CostantinoCM, HaflerDA: FOXP3+ regulatory T cells in the human immune system.Nat. Rev. Immunol.10(7), 490–500(2010).
  • Itoh M , TakahashiT, SakaguchiNet al.: Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.J. Immunol.162(9), 5317–5326(1999).
  • Hori S , NomuraT, SakaguchiS: Control of regulatory T cell development by the transcription factor Foxp3.Science299(5609), 1057–1061(2003).
  • Takahashi T , TagamiT, YamazakiSet al.: Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.J. Exp. Med.192(2), 303–310(2000).
  • McHugh RS , WhittersMJ, PiccirilloCAet al.: CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.Immunity16(2), 311–323(2002).
  • Mandapathil M , SzczepanskiMJ, SzajnikMet al.: Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.J. Biol. Chem.285(36), 27571–27580(2010).
  • Mandapathil M , LangS, GorelikE, WhitesideTL: Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression.J. Immunol. Methods.346(1–2), 55–63(2009).
  • Borsellino G , KleinewietfeldM, Di MitriDet al.: Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood110(4), 1225–1232(2007).
  • Barthlott T , MoncrieffeH, VeldhoenMet al.: CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production.Int. Immunol.17(3), 279–288(2005).
  • Munn DH , SharmaMD, MellorAL: Ligation of B7–1/B7–2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.J. Immunol.172(7), 4100–4110(2004).
  • Sojka DK , HuangYH, FowellDJ: Mechanisms of regulatory T-cell suppression – a diverse arsenal for a moving target.Immunology124(1), 13–22(2008).
  • Cao X , CaiSF, FehnigerTAet al.: Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.Immunity27(4), 635–646(2007).
  • Fazekas de St Groth B , LandayAL: Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response?AIDS22(6), 671–683(2008).
  • Seddiki N , KelleherAD: Regulatory T cells in HIV infection: who‘s suppressing what?Curr HIV/AIDS Rep.5(1), 20–26(2008).
  • Kinter A , McNallyJ, RigginL, JacksonR, RobyG, FauciAS: Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals.Proc. Natl Acad. Sci. USA104(9), 3390–3395(2007).
  • Krathwohl MD , SchackerTW, AndersonJL: Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects.J. Infect. Dis.193(4), 494–504(2006).
  • Ji J , CloydMW: HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.Int. Immunol.21(3), 283–294(2009).
  • Becker C , TaubeC, BoppTet al.: Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells.Blood114(6), 1263–1269(2009).
  • Kinter AL , HorakR, SionMet al.: CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.AIDS Res. Hum. Retroviruses23(3), 438–450(2007).
  • Thorborn G , PomeroyL, IsohanniH, PerryM, PetersB, VyakarnamA: Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.PLoS ONE5(2), E9254 (2010).
  • Ndhlovu LC , LooCP, SpottsG, NixonDF, HechtFM: FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.J. Leukoc. Biol.83(2), 254–262(2008).
  • Jiao Y , FuJ, XingSet al.: The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressors.Immunology128(1 Suppl.), E366–E375 (2009).
  • Giorgi JV , HultinLE, McKeatingJAet al.: Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.J. Infect. Dis.179(4), 859–870(1999).
  • Cecchinato V , TryniszewskaE, MaZMet al.: Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection.J. Immunol.180(8), 5439–5447(2008).
  • Weiss L , PikettyC, AssoumouLet al.: Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.PLoS ONE5(7), E11659 (2010).
  • Brenchley JM , PaiardiniM, KnoxKSet al.: Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.Blood112(7), 2826–2835(2008).
  • Favre D , LedererS, KanwarBet al.: Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection.PLoS Pathog.5(2), E1000295 (2009).
  • Prendergast A , PradoJG, KangYHet al.: HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells.AIDS24(4), 491–502(2010).
  • Favre D , MoldJ, HuntPWet al.: Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of Th17 to regulatory T cells in HIV disease.Sci. Transl. Med.2(32), 32ra36 (2010).
  • Cao W , JamiesonBD, HultinLE, HultinPM, DetelsR: Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression.AIDS Res. Hum. Retroviruses25(2), 183–191(2009).
  • Kovacs JA , BaselerM, DewarRJet al.: Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.N. Engl. J. Med.(9), 567–575(1995).
  • Kovacs JA , VogelS, AlbertJMet al.: Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.N. Engl. J. Med.335(18), 1350–1356(1996).
  • Vogler MA , TepplerH, GelmanRet al.: Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).J. Acquir. Immune Defic. Syndr.36(1), 576–587(2004).
  • Goujard C , MarcellinF, Hendel-ChavezHet al.: Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 randomized study.AIDS Res. Hum. Retroviruses23(9), 1105–1113(2007).
  • Abrams D , LevyY, LossoMHet al.: Interleukin-2 therapy in patients with HIV infection.N. Engl. J. Med.361(16), 1548–1559(2009).
  • Asmuth DM , MurphyRL, RosenkranzSLet al.: Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon α-2a in HIV-1-monoinfected participants: a Phase II clinical trial.J. Infect. Dis.201(11), 1686–1696(2010).
  • Levy Y , LacabaratzC, WeissLet al.: Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.J. Clin. Invest.119(4), 997–1007(2009).
  • Sereti I , DunhamRM, SpritzlerJet al.: IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.Blood113(25), 6304–6314(2009).
  • Day CL , KaufmannDE, KiepielaPet al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.Nature443(7109), 350–354(2006).
  • Blackburn SD , ShinH, HainingWNet al.: Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.Nat. Immunol.10(1), 29–37(2009).
  • Macatangay BJ , RinaldoCR: PD-1 blockade: a promising immunotherapy for HIV?Cellscience5(4), 61–65(2009).
  • Kassu A , MarcusRA, D‘SouzaMBet al.: Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection.J. Immunol.185(5), 3007–3018(2010).
  • Velu V , TitanjiK, ZhuBet al.: Enhancing SIV-specific immunity in vivo by PD-1 blockade.Nature458(7235), 206–210(2009).
  • Breton G , Yassine-DiabB, CohnLet al.: siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8+ T cells from HIV-1-infected individuals.J. Clin. Immunol.29(5), 637–645(2009).
  • Connolly NC , WhitesideTL, WilsonC, KondraguntaV, RinaldoCR, RiddlerSA: Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.Clin. Vaccine Immunol.15(2), 284–292(2008).
  • Routy JP , BoulasselMR, Yassine-DiabBet al.: Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.Clin. Immunol.134(2), 140–147(2010).
  • Lu W , ArraesLC, FerreiraWT, AndrieuJM: Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.Nat. Med.10(12), 1359–1365(2004).
  • Garcia F , LejeuneM, ClimentNet al.: Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.J. Infect. Dis.191(10), 1680–1685(2005).
  • Wei S , KryczekI, EdwardsRPet al.: Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.Cancer Res.67(15), 7487–7494(2007).
  • Weiss L , LetimierFA, CarriereMet al.: In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients.Proc. Natl Acad. Sci. USA107(23), 10632–10637(2010).
  • Ndhlovu LC , SinclairE, EplingLet al.: IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery.J. Clin. Immunol.30(5), 681–692(2010).
  • Levings MK , SangregorioR, GalbiatiF, SquadroneS, de Waal Malefyt R, Roncarolo MG: IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol.166(9), 5530–5539(2001).
  • Luik A , KnappS, ThurszM, ThomasHC, SchlaakJF: Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-α.J. Interferon Cytokine Res.24(10), 585–593(2004).
  • Franceschini D , ParoliM, FrancavillaVet al.: PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.J. Clin. Invest.119(3), 551–564(2009).
  • Radziewicz H , DunhamRM, GrakouiA: PD-1 tempers Tregs in chronic HCV infection.J. Clin. Invest.119(3), 450–453(2009).
  • Sachdeva M , FischlMA, PahwaR, SachdevaN, PahwaS: Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients.J. Acquir. Immune Defic. Syndr.54(5), 447–454(2010).
  • Amarnath S , CostanzoCM, MariottiJet al.: Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.PLoS Biol.8(2), E1000302 (2010).
  • Macatangay BJ , SzajnikME, WhitesideTL, RiddlerSA, RinaldoCR: Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.PLoS ONE5(3), e9852 (2010).
  • Banerjee DK , DhodapkarMV, MatayevaE, SteinmanRM, DhodapkarKM: Expansion of FOXP3 high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients.Blood108(8), 2655–2661(2006).
  • Berntsen A , BrimnesMK, thor StratenP, SvaneIM: Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2. J. Immunother.33(4), 425–434(2010).
  • Onishi Y , FehervariZ, YamaguchiT, SakaguchiS: Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.Proc. Natl Acad. Sci. USA105(29), 10113–10118(2008).
  • O‘Gorman WE , DoomsH, ThorneSHet al.: The initial phase of an immune response functions to activate regulatory T cells.J. Immunol.183(1), 332–339(2009).
  • Valentin A , von GegerfeltA, RosatiMet al.: Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit. Vaccine8(8), 1962–1974(2010).
  • Rech AJ , VonderheideRH: Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells.Ann. NY Acad. Sci.1174, 99–106(2009).
  • Jacobs JF , PuntCJ, LesterhuisWJet al.: Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a Phase I/II study in metastatic melanoma patients.Clin. Cancer Res.16(20), 5067–5078(2010).
  • Saha A , ChatterjeeSK: Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer.Scand. J. Immunol.71(2), 70–82(2010).
  • Coe D , BegomS, AddeyC, WhiteM, DysonJ, ChaiJG: Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.Cancer Immunol. Immunother.59(9), 1367–1377(2010).
  • Morrow MP , PankhongP, LaddyDJet al.: Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity.Blood113(23), 5868–5877(2009).
  • Hryniewicz A , BoassoA, Edghill-SmithYet al.: CTLA-4 blockade decreases TGF-β, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques.Blood108(12), 3834–3842(2006).
  • Sarnaik AA , WeberJS: Recent advances using anti-CTLA-4 for the treatment of melanoma.Cancer J.15(3), 169–173(2009).
  • Hershfield MS . New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur. J. Immunol.35(1), 25–30(2005).
  • Deaglio S , DwyerKM, GaoWet al.: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.J. Exp. Med.204(6), 1257–1265(2007).
  • Douek DC , RoedererM, KoupRA: Emerging concepts in the immunopathogenesis of AIDS.Annu. Rev. Med.60, 471–484(2009).
  • Thomson CW , LeeBP, ZhangL: Double-negative regulatory T cells: non-conventional regulators.Immunol. Res.35(1–2), 163–178(2006).
  • Bouaziz JD , YanabaK, TedderTF: Regulatory B cells as inhibitors of immune responses and inflammation.Immunol. Rev.224, 201–214(2008).
  • Gabrilovich DI , NagarajS: Myeloid-derived suppressor cells as regulators of the immune system.Nat. Rev. Immunol.9(3), 162–174(2009).
  • Scholzen A , MinigoG, PlebanskiM: Heroes or villains? T regulatory cells in malaria infection.Trends Parasitol.26(1), 16–25(2010).
  • He XY , XiaoL, ChenHBet al.: T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients.Eur. J. Clin. Microbiol. Infect. Dis.29(6), 643–650(2010).
  • Sturm N , TheluMA, CamousXet al.: Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.J. Hepatol.53(1), 25–35(2010).
  • Rallon NI , BarreiroP, SorianoV, Garcia-SamaniegoJ, LopezM, BenitoJM: Elevated TGF-β1 levels might protect HCV/HIV-coinfected patients from liver fibrosis.Eur. J. Clin. Invest. DOI: 10.1111/j.1365-2362.2010.02381 (2010) (Epub ahead of print).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.